Detail
LncRNA Name | lncRNA-NEF |
Synonyms | NA |
Region | NA Sequence |
Ensembl | NA |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 M8170/3 |
Methods | RNA-seq, qPCR, Western blot |
Sample | liver cell lines (MiHA, SK-HEP-1, PLC/PRF/5, Hep3B and Huh7, HepG2, Bel7404) |
Expression Pattern | down-regulated |
Function Description | the lncRNA-NEF was transcriptionally activated by EMT suppressor FOXA2 and frequently downregulated in HCC cell lines as well as clinical specimens. Although enhanced expression of lncRNA-NEF did not affect tumor cell growth, ectopic expression of lncRNA-NEF significantly suppressed EMT program and cell migration. Animal studies validated that lncRNA-NEF alleviated in vivo tumor metastasis and protected mice from tumor-induced mortality. Interestingly, we verified that lncRNA-NEF acted as a novel activator of its neighbor gene FOXA2, which formed a positive feedback loop. Subsequent studies revealed that lncRNA-NEF physically interacted with B-catenin to increase the binding of GSK3B with B-catenin and therefore promoted the inhibitory phosphorylation of B-catenin, leading to the suppression on Wnt/B-catenin signaling and activation of FOXA2 expression. |
Pubmed ID | 29311643 |
Year | 2018 |
Title | LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/B-catenin signaling. |
External Links |
Links for lncRNA-NEF | GenBank HGNC lncrnadb Noncode |
Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.